3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
15
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Stomach Neoplasms
2
Neoplasm Metastasis
2
Carcinoma
2
Spinocerebellar Degenerations
1
Rectal Neoplasms
1
Neoplasms
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Digestive System Diseases
1
Advanced Colorectal Cancer
1
Adenocarcinoma Of Esophagus
1
Adenocarcinoma
1
Interventions
trifluridine tipiracil drug combination
1
regorafenib
1
Oxaliplatin
1
Immune Checkpoint Inhibitors
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Spinocerebellar Degenerations
×
trifluridine tipiracil drug combination
×
Clear all
NCT05328908
2025-08-13
RELATIVITY-123
Bristol-Myers Squibb
Phase 3
Terminated
770 enrolled